Moore Capital Management’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

Moore Capital Management’s Portfolio TDACW Stock Details TDACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$71.2K	Hold	50,000	–	–	﹤0.01%	616
2026 Q1	$6K	Hold	50,000	–	–	﹤0.01%	622
2025 Q4	$15.5K	Hold	50,000	–	–	﹤0.01%	641
2025 Q3	$14.5K	Hold	50,000	–	–	﹤0.01%	595
2025 Q2	$14.5K	Buy	+50,000	New	+$10.3K	﹤0.01%	514

Other funds holding TDACW

Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return

LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return

Rivernorth Capital Management West Palm Beach, Florida $2.1B AUM 2.15% 1-Year Est. Return

Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return

Moore Capital Management's TDACW Position: Q2 2026 in Review

Moore Capital Management held its Translational Development Acquisition Corp Warrants (TDACW) position steady in Q2 2026 at 50,000 shares worth $71.2K. The position accounts for ﹤0.01% of the portfolio, ranked #616.

Moore Capital Management first reported a position in TDACW in Q2 2025 and has held it in 5 quarters since. 28 funds tracked by Wall St. Rank hold TDACW as of Q2 2026.

Moore Capital Management held 50,000 shares of Translational Development Acquisition Corp Warrants worth $71.2K as of Q2 2026.
Moore Capital Management left its Translational Development Acquisition Corp Warrants share count unchanged in Q2 2026.
Translational Development Acquisition Corp Warrants made up ﹤0.01% of Moore Capital Management's portfolio in Q2 2026, its #616 holding.
Moore Capital Management first reported a position in Translational Development Acquisition Corp Warrants in Q2 2025 and has held it in 5 quarters since.
28 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q2 2026.

Based on Moore Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.